Allscripts (MDRX) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St set for higher open as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Allscripts (MDRX) PT Raised to $21 at Deutsche Bank Following Modest 'Beat'
November 4, 2022 1:23 PM EDTDeutsche Bank analyst George Hill raised the price target on Allscripts (NASDAQ: MDRX) to $21.00 (from $20.00) while maintaining a Buy rating following Q3 beat.
The analyst commented, "Allscripts reported a modest Q3 earnings, above streets expectations. The company reported an adjusted EPS of... More
